Skip to main content

Ceprotin Disease Interactions

There are 2 disease interactions with Ceprotin (protein c).

Moderate

Protein C concentrate human (applies to Ceprotin) bleeding

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Bleeding Associated with Coagulation Defect

In clinical studies, several bleeding episodes have been observed with the use of protein C concentrate human. Simultaneous administration of protein C concentrate human and tissue plasminogen activator (tPA) may further increase the risk of bleeding from tPA, specially in those at risk. Care should be taken when using this agent in patients at risk of bleeding.

References

  1. "Product Information. Ceprotin (protein C)." Baxter Healthcare Corporation (2022):
Moderate

Protein C concentrate human (applies to Ceprotin) renal dysfunction

Moderate Potential Hazard, Moderate plausibility.

Protein C concentrate human contains sodium >200 mg. Inform patients on a low sodium diet that the quantity of sodium in the maximum daily dose of protein C concentrate human exceeds 200 mg. Care should be exercised when using this agent in patients with renal impairment due to the risk of sodium overload or those on a low sodium diet.

References

  1. "Product Information. Ceprotin (protein C)." Baxter Healthcare Corporation (2022):

Ceprotin drug interactions

There are 38 drug interactions with Ceprotin (protein c).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer